H Jules & Company Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.52 Cr
as on 16-11-2024
- Company Age 33 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.34 Cr
as on 16-11-2024
- Revenue 19.02%
(FY 2023)
- Profit 212.89%
(FY 2023)
- Ebitda -624.18%
(FY 2023)
- Net Worth 517.30%
(FY 2023)
- Total Assets 2.31%
(FY 2023)
About H Jules & Company
The Corporate was formerly known as H Jules & Company Private Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 1.52 Cr.
The company has closed loans amounting to ₹3.34 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gajanan Bangadkar, Hussain Rafi, Bhavana, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1991PLC062174
- Company No.
062174
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Jun 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at H Jules & Company?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gajanan Bangadkar | Whole-Time Director | 15-Dec-2011 | Current |
Hussain Rafi | Whole-Time Director | 01-Jul-2023 | Current |
Bhavana | Whole-Time Director | 13-Nov-2019 | Current |
Himanshuranjan Tiwari | Director | 01-Jun-2022 | Current |
Naresh Gaikwad | Whole-Time Director | 01-Jul-2023 | Current |
Financial Performance of H Jules & Company.
H Jules & Company Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 19.02% increase. The company also saw a substantial improvement in profitability, with a 212.89% increase in profit. The company's net worth Soared by an impressive increase of 517.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of H Jules & Company?
In 2023, H Jules & Company had a promoter holding of 24.29% and a public holding of 75.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Saif Health Remedies Private LimitedActive 24 years 7 months
Himanshuranjan Tiwari is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Bank Of Baroda Creation Date: 30 Dec 2002 | ₹2.81 Cr | Satisfied |
Bank Of Baroda Creation Date: 20 Oct 1999 | ₹1.00 M | Satisfied |
Union Bank Of India Creation Date: 01 Jun 1999 | ₹1.60 M | Satisfied |
How Many Employees Work at H Jules & Company?
Unlock and access historical data on people associated with H Jules & Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of H Jules & Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped H Jules & Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.